Showing results (61-70 of 84) with videos related to
Sort By:
Pageof 9
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 1, 2014
Pleckstrin homology domain containing 6 protein (PLEKHA6) polymorphisms are associated with psychopathology and response to treatment in schizophrenic patientsIlja Spellmann, Dan Rujescu, Richard Musil, et al.Journal of Psychiatric Research|July 6, 2010
Homer-1 polymorphisms are associated with psychopathology and response to treatment in schizophrenic patientsIlja Spellmann, Dan Rujescu, Richard Musil, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 26, 2010
Outcomes of 1014 naturalistically treated inpatients with major depressive episodeFlorian Seemüller, Michael Riedel, Michael Obermeier, et al.European Archives of Psychiatry and Clinical Neuroscience|September 12, 2012
No influence of brain-derived neurotrophic factor (BDNF) polymorphisms on treatment response in a naturalistic sample of patients with major depressionRichard Musil, Peter Zill, Florian Seemüller, et al.European Archives of Psychiatry and Clinical Neuroscience|March 5, 2014
Three-Year long-term outcome of 458 naturalistically treated inpatients with major depressive episode: severe relapse rates and risk factorsFlorian Seemüller, Sebastian Meier, Michael Obermeier, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 16, 2012
Genetics of emergent suicidality during antidepressive treatment--data from a naturalistic study on a large sample of inpatients with a major depressive episodeRichard Musil, Peter Zill, Florian Seemüller, et al.Journal of Clinical Psychopharmacology|August 29, 2012
Akathisia and suicidal ideation in first-episode schizophreniaFlorian Seemüller, Rebecca Schennach, Andreas Mayr, et al.BMJ Mental Health|April 4, 2025
Measuring social environment factors of inpatients and outpatients with depression in Germany: a cross-sectional studyPetra Schoenweger, Julia Eder, Lisa Pfeiffer, et al.Psychiatry Research|March 6, 2023
CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders - Results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority studyKirsten R Müller-Vahl, Anna Pisarenko, Natalia Szejko, et al.European Archives of Psychiatry and Clinical Neuroscience|September 28, 2014
What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trialRebecca Schennach, Michael Riedel, Michael Obermeier, et al.Pageof 9